Drug Shortage Report for MYLAN-VERAPAMIL SR
| Report ID | 121246 |
| Drug Identification Number | 02450496 |
| Brand name | MYLAN-VERAPAMIL SR |
| Common or Proper name | VERAPAMIL |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | DORMANT |
| Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
| Strength(s) | 240MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT, 500BT |
| ATC code | C08DA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-11-25 |
| Actual start date | 2020-11-25 |
| Estimated end date | 2021-01-12 |
| Actual end date | 2020-11-30 |
| Shortage status | Resolved |
| Updated date | 2020-12-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v31 | 2020-12-01 | English | Compare |
| v30 | 2020-11-30 | French | Compare |
| v29 | 2020-11-30 | English | Compare |
| v28 | 2020-11-25 | English | Compare |
| v27 | 2020-11-10 | French | Compare |
| v26 | 2020-11-10 | English | Compare |
| v25 | 2020-11-05 | English | Compare |
| v24 | 2020-11-03 | French | Compare |
| v23 | 2020-11-03 | English | Compare |
| v22 | 2020-10-20 | French | Compare |
| v21 | 2020-10-20 | English | Compare |
| v20 | 2020-10-14 | French | Compare |
| v19 | 2020-10-14 | English | Compare |
| v18 | 2020-10-14 | French | Compare |
| v17 | 2020-10-14 | English | Compare |
| v16 | 2020-09-30 | French | Compare |
| v15 | 2020-09-30 | English | Compare |
| v14 | 2020-09-22 | French | Compare |
| v13 | 2020-09-22 | English | Compare |
| v12 | 2020-09-14 | French | Compare |